PNC Financial Services Group’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$674K Buy
23,336
+2,617
+13% +$70.6K ﹤0.01% 1603
2026
Q1
$375K Buy
20,719
+9,585
+86% +$183K ﹤0.01% 1894
2025
Q4
$242K Buy
11,134
+456
+4% +$13.1K ﹤0.01% 2155
2025
Q3
$348K Buy
10,678
+3,742
+54% +$138K ﹤0.01% 1895
2025
Q2
$246K Buy
6,936
+2,020
+41% +$65.5K ﹤0.01% 2076
2025
Q1
$167K Buy
4,916
+3,238
+193% +$116K ﹤0.01% 2312
2024
Q4
$54.6K Sell
1,678
-1,059
-39% -$43.9K ﹤0.01% 3060
2024
Q3
$133K Buy
2,737
+750
+38% +$40K ﹤0.01% 2490
2024
Q2
$88K Buy
1,987
+765
+63% +$35.3K ﹤0.01% 2704
2024
Q1
$68.5K Buy
1,222
+196
+19% +$11.8K ﹤0.01% 2823
2023
Q4
$61.7K Sell
1,026
-322
-24% -$20.4K ﹤0.01% 2862
2023
Q3
$90.5K Buy
1,348
+472
+54% +$32.8K ﹤0.01% 2626
2023
Q2
$60.5K Buy
876
+369
+73% +$24.1K ﹤0.01% 2946
2023
Q1
$24.4K Buy
507
+167
+49% +$8.17K ﹤0.01% 3402
2022
Q4
$17K Sell
340
-10
-3% -$484 ﹤0.01% 3550
2022
Q3
$15K Buy
350
+227
+185% +$10.7K ﹤0.01% 3581
2022
Q2
$7K Buy
123
+42
+52% +$1.77K ﹤0.01% 3913
2022
Q1
$3K Sell
81
-230
-74% -$9.09K ﹤0.01% 4112
2021
Q4
$15K Buy
+311
New +$15.8K ﹤0.01% 3656

Other funds holding LEGN

PNC Financial Services Group's LEGN Position: Q2 2026 in Review

PNC Financial Services Group increased its Legend Biotech (LEGN) stake by 13% in Q2 2026, buying an estimated $70.6K and bringing the position to 23,336 shares worth $674K. The position accounts for ﹤0.01% of the portfolio, ranked #1603.

PNC Financial Services Group first reported a position in LEGN in Q4 2021 and has held it in 19 quarters since. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • PNC Financial Services Group held 23,336 shares of Legend Biotech worth $674K as of Q2 2026.
  • PNC Financial Services Group bought 2,617 Legend Biotech shares in Q2 2026, an estimated $70.6K.
  • Legend Biotech made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1603 holding.
  • PNC Financial Services Group first reported a position in Legend Biotech in Q4 2021 and has held it in 19 quarters since.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.